Skip to content

Clinical trials

Completed Phase 2/3 Heart Failure trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2/3 Status: Completed Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20034
20042
20055
20061
20074
20082
20093
20101
20115
20121
20132
20144
20152
20161
20181
20201
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation7
Columbia University2
Hebei Medical University2
Instituto de Cardiologia do Rio Grande do Sul2
Virginia Commonwealth University2
Abbott RDx Cardiometabolic1
Advanz Pharma1
AstraZeneca1
Barts & The London NHS Trust1
Belfast Health and Social Care Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure44
Cardiomyopathy, Dilated3
Inflammation3
Cardiomyopathies2
Coronary Artery Disease2
Diabetes Mellitus2
Heart Diseases2
Myocardial Ischemia2
Pulmonary Disease, Chronic Obstructive2
Renal Insufficiency2

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.